Net Cash Provided by (Used in) Operating Activities |
2.96M |
USD |
+122% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-577K |
USD |
-147% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-268K |
USD |
+64.5% |
Q3 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
750K |
shares |
0% |
Q3 2024 |
Q1 2025 |
Common Stock, Shares, Issued |
734K |
shares |
0% |
Q3 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
2.11M |
USD |
+17.7% |
Q3 2024 |
Q1 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
1.04M |
USD |
-35.6% |
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
36.3M |
USD |
+7.57% |
Q2 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
36.3M |
USD |
+7.57% |
Q2 2024 |
FY 2024 |
Depreciation |
821K |
USD |
+30.9% |
Q3 2023 |
Q1 2024 |
Payments to Acquire Property, Plant, and Equipment |
268K |
USD |
-64.5% |
Q3 2024 |
Q1 2025 |
Deferred Income Tax Expense (Benefit) |
-3K |
USD |
+99.6% |
Q3 2022 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
14.4M |
USD |
+9.84% |
Q2 2024 |
FY 2024 |
Unrecognized Tax Benefits |
1.67M |
USD |
0% |
Q2 2024 |
FY 2024 |
Depreciation, Depletion and Amortization |
546K |
USD |
+19% |
Q3 2022 |
Q1 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
8.41M |
USD |
-38.3% |
Q2 2022 |
FY 2023 |
Interest Expense |
824K |
USD |
+64.1% |
Q3 2024 |
Q1 2025 |